[NMusers] Starting dose in cancer patients

From: Venkat Pokiri <pokiri75_at_gmail.com>
Date: Thu, 27 Sep 2007 12:13:07 -0600

Dear all;

I am just wondering whether any regulatory (FDA, MHRA etc. ) guidance
available on the starting dose of molecular targeted therapy (MTT) agents
such as tyrosine kinase inhibitors in cancer patients. I would appreciate
your thoughts on this topic.

Best regards,

VPokiri

>

Received on Thu Sep 27 2007 - 14:13:07 EDT

This message: [ Message body ]
Next message: Alison Boeckmann: "Re: [NMusers] bug/feature in $AES"
Previous message: Leonid Gibiansky: "Re: [NMusers] bug/feature in $AES"

Contemporary messages sorted: [ by date ] [ by thread ] [ by subject ] [ by author ] [ by messages with attachments ]

This archive was generated by hypermail 2.2.0 : Tue Nov 06 2007 - 15:07:28 EST